Dhingra, Sameer, and Mamta Sachdeva. “Expanding Horizons in the Treatment of Mantle Cell Lymphoma: Ibrutinib a Novel BTK-Targeting Inhibitor”. International Journal of Basic & Clinical Pharmacology 3, no. 1 (January 23, 2017): 249–254. Accessed March 29, 2024. https://www.ijbcp.com/index.php/ijbcp/article/view/991.